Archives: Agenda
Morning Refreshments and Networking
PRIZE DRAW
Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!
Morning refreshments and networking
PANEL DISCUSSION: Accelerating Study Start-Up: Driving Operational Readiness and Trial Momentum for Faster Trial Launches
- Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve
- Streamlining protocol finalization, regulatory submissions, and feasibility assessments to shorten start-up timelines
- Identifying and engaging the right sites as part of a broader operational readiness strategy
- Coordinating cross-functional teams, vendor partnerships, and internal stakeholders to ensure smooth study initiation
- Implementing robust onboarding, training, and communication plans to set the trial up for success from day one
- Reducing contract cycle times to accelerate study start-up
Moderator: Michael Murphy, Director, Legal & Associate General Counsel, Ionis
Interactive Speaker-Hosted Breakfast Breakout Discussions
With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
| Discussion 1 | Turning Inspection Fears into Operational Readiness In An Uncertain Regulatory Environment
Hosted by Regina Griffin, Associate Director, Clinical Operations, Autobahn Therapeutics |
| Discussion 2 | Vendor Oversight – Whose Job Is It Anyways?
Hosted by Denise Deegan, Associate Director, Clinical Operations, Pionyr Immunotherapeutics |
| Discussion 3 |
Beyond the Pilot: Turning AI into a Scalable Drug Development Strategy Hosted by Shivam Patel, Monitoring Oversight and AI Automation Lead, Moderna |
| Discussion 4 | Breaking Down Data Silos: Creating a More Connected Clinical Trial Ecosystem
Hosted by Wei Cheng, Executive Director, Apogee Therapeutics |
| Discussion 5 | Why Patients Walk Away from Clinical Trials and What the Industry Still Gets Wrong |
Chair’s closing remarks
NEW FOR 2026! INDUSTRY HOT TAKES PANEL
This panel will take place in TRACK A: Outsourcing & Clinical Operations
1 stage, a variety of rapid-fire opinions, bold predictions and myth-busting from experts across the industry. Audience members will vote, agree or disagree, on each hot take! There’ll be a chance for the audience to pose some questions to the panel too.
The panel will answer the following:
- Biggest mistake in clinical trials today
- One thing pharma should stop doing
- One prediction for 2030
- What’s overhyped and what’s worth the hype
- What vendors misunderstand
- Where trials fail most often
- Biggest recruitment mistake
- Hot takes from the audience
Moderator: Robert Loll, SVP, Business Development & Strategic Planning, Praxis
RFPs and How to Improve the Communication Of Specifications With CROs To Get More Of What You Want And Derisk Your Programs
- Better RFP specifications lead to better proposals, pricing, timelines, and accountability.
- The protocol is not the specification, define the operational assumptions CROs need to price and plan accurately.
- Separate requirements, assumptions, and CRO recommendations so proposals can be compared consistently.
- Standardize bid grids and key assumptions while still allowing CROs to propose differentiated solutions.
- Surface exclusions, dependencies, and hidden assumptions early, these are often the source of future change orders.
- Build uncertainty into the RFP with scenarios for sites, countries, enrollment, timelines, and amendments.
- Use the RFP and bid defense to test how the CRO thinks, not just what they charge.
- Carry proposal commitments into the contract, governance plan, KPIs, and operating model.
- The goal is not simply a better bid, it is better communication, fewer surprises
Unlocking better protocols: How ICON and Advarra reduce delays, amendments and costs
- Identify protocol risks earlier through integrated clinical, operational and site-level perspectives.
- Design more executable studies by aligning protocol ambition with real-world site and patient needs.
- Reduce avoidable delays, amendments and costs by building feasibility into the protocol from the outset.